Modes of action of trichloroethylene for kidney tumorigenesis

被引:83
作者
Lash, LH
Parker, JC
Scott, CS
机构
[1] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA
[2] US EPA, Natl Ctr Environm Assessment, Washington, DC 20460 USA
关键词
alpha(2u)-globulin; cell proliferation; cysteine conjugate beta-lyase; genotoxicity; kidney; oxidative stress; peroxisome proliferation; renal cancer; trichloroethylene;
D O I
10.1289/ehp.00108s2225
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This article focuses on the various models for kidney toxicity due to trichloroethylene (TCE) and its glutathione-dependent metabolites, in particular S-(1,2-dichlorovinyl)-L-cysteine. Areas of controversy regarding the relative importance of metabolic pathways, species differences in toxic responses, rates of generation of reactive metabolites, and dose-dependent phenomena are highlighted. The first section briefly reviews information on the incidence and risk factors of kidney cancer in the general U.S. population. Epidemiological data on incidence of kidney cancer in male workers exposed occupationally to TCE are also summarized. This is contrasted with cancer bioassay data from laboratory animals, that highlights sex and species differences and. consequently, the difficulties in making risk assessments for humans based on animal data. The major section of the article considers proposed modes of action for TCE or its metabolites in kidney, including peroxisome proliferation, alpha(2u)-globulin nephropathy, genotoxicity, and acute and chronic toxicity mechanisms. The latter comprise oxidative stress, alterations in calcium ion homeostasis, mitochondrial dysfunction, protein alkylation, cellular repair processes, and alterations in gene expression and cell proliferation. Finally, the status of risk assessment for TCE based on the kidneys as a target organ and remaining questions and research needs are discussed.
引用
收藏
页码:225 / 240
页数:16
相关论文
共 213 条
[41]  
Crebelli R, 1982, Ann Ist Super Sanita, V18, P117
[42]   Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells [J].
Cummings, BS ;
Lash, LH .
TOXICOLOGICAL SCIENCES, 2000, 53 (02) :458-466
[43]  
CUMMINGS BS, IN PRESS BIOCH PHARM
[44]  
CUMMINGS BS, IN PRESS J PHARM EXP
[45]   DICHLOROVINYL CYSTEINE (DCVC) IN THE MOUSE KIDNEY - TISSUE-BINDING AND TOXICITY AFTER GLUTATHIONE DEPLETION AND PROBENECID TREATMENT [J].
DARNERUD, PO ;
BRANDT, I ;
FEIL, VJ ;
BAKKE, JE .
ARCHIVES OF TOXICOLOGY, 1989, 63 (05) :345-350
[46]  
DAVID NJ, 1989, BRIT J IND MED, V46, P347
[47]  
Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001
[48]  
DECRAEMER D, 1994, J LIPID RES, V35, P1241
[49]   THIOACYLATING INTERMEDIATES AS METABOLITES OF S-(1,2-DICHLOROVINYL)-L-CYSTEINE AND S-(1,2,2-TRICHLOROVINYL)-L-CYSTEINE FORMED BY CYSTEINE CONJUGATE BETA-LYASE [J].
DEKANT, W ;
BERTHOLD, K ;
VAMVAKAS, S ;
HENSCHLER, D ;
ANDERS, MW .
CHEMICAL RESEARCH IN TOXICOLOGY, 1988, 1 (03) :175-178
[50]  
DEKANT W, 1987, DRUG METAB DISPOS, V15, P702